Morgan Stanley downgraded Ardent Health from Overweight to Equal-Weight
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/17/2025 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 11/14/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 10/14/2025 | $19.00 | Neutral | Goldman |
| 9/10/2025 | $17.00 | Buy | UBS |
| 7/16/2025 | $14.60 | Neutral → Underperform | BofA Securities |
| 12/17/2024 | $20.00 | Neutral | Analyst |
| 11/6/2024 | $22.00 → $19.00 | Buy → Neutral | BofA Securities |
| 10/11/2024 | $24.00 | Overweight | KeyBanc Capital Markets |
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
8-K - Ardent Health, Inc. (0001756655) (Filer)
10-Q - Ardent Health, Inc. (0001756655) (Filer)
8-K - Ardent Health, Inc. (0001756655) (Filer)
KeyBanc Capital Markets downgraded Ardent Health from Overweight to Sector Weight
Morgan Stanley downgraded Ardent Health from Overweight to Equal-Weight
Goldman initiated coverage of Ardent Health with a rating of Neutral and set a new price target of $19.00
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced its Board of Directors has authorized a share repurchase program of up to $50 million. "This authorization reflects our conviction in the fundamental strength of Ardent's business and our ability to deliver sustained, long-term shareholder value," said Marty Bonick, President and Chief Executive Officer. "With a strong balance sheet and significant financial capacity, we are well positioned to act decisively when market conditions present attractive opportunities. The program enhances our flexibility to deploy capital in ways that align with our view of intri
Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2025. Third Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.58 billion 8.8% growth Y/Y Net Loss Attributable to Ardent Health $23 million Adjusted EBITDA(1) $143 million 46.3% growth Y/Y Adjusted EBITDAR(1)
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the 2025 Stephens Annual Investment Conference on Tuesday, Nov. 18, 2025, in Nashville, Tennessee. Members of the management team will participate in a fireside chat on Nov. 18, 2025, at 11 a.m. ET. A live audio webcast of the event will be available in the Investor Relations section of the Ardent Health website at ir.ardenthealth.com. A replay of the event will be accessible on the same page following the session. In conjunction with the conference, the Ardent Health management team will be available to participate in one
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2025 results after the market closes on Wednesday, November 12, 2025. A conference call will be held the following day, Thursday, November 13, 2025, at 9 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2025 results after the market closes on Tuesday, August 5, 2025. A conference call will be held the following day, Wednesday, August 6, 2025, at 10 a.m. ET to review the company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start
Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended March 31, 2025. First Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.50 billion 4.0% growth Y/Y Net Income Attributable to Ardent Health $41 million Adjusted EBITDA(1) $98 million 2.5% growth Y/Y Adjusted EBITDAR(1) $139 million